Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat

Cancer Research

Volumn 64, Issue 18, 2004, Pages 6797-6804

  Davidson, Laurie A ^a   Nguyen, Danh V ^b   Hokanson, Regina M ^a   Callaway, Evelyn S ^a   Isett, Robert B ^a   Turner, Nancy D ^a   Dougherty, Edward R ^a   Wang, Naisyin ^a   Lupton, Joanne R ^a   Carroll, Raymond J ^a   Chapkin, Robert S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; OLIVE OIL; OMEGA 3 FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; DIET; DNA ADDUCT; DNA MICROARRAY; DOWN REGULATION; FACTORIAL ANALYSIS; FAT INTAKE; GENE CONTROL; GENE EXPRESSION; INTESTINE CRYPT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; AZOXYMETHANE; CARCINOGENS; CELL DIFFERENTIATION; COLONIC NEOPLASMS; DISEASE PROGRESSION; DNA ADDUCTS; DOWN-REGULATION; EATING; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; FISH OILS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES; UP-REGULATION; WEIGHT GAIN;

EID: 4644359644     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1068     Document Type: Article

References (64)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA - Cancer J Clin 2002;52(1):23-47.
2. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993;15(2):499-545.
3. Reddy BS, Burill C, Rigotty J. Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1991;51(2):487-91.
4. Bull AW, Souiller BK, Wilson PS, Hayden MT, Nigro ND. Promotion of azoxymethane-induced intestinal cancer by high-fat diet in rats. Cancer Res 1979;39(12): 4956-9.
5. Chang WL, Chapkin RS, Lupton JR. Fish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation. J Nutr 1998;128(3):491-7.
6. Anti M, Armelao F, Marra G, et al. Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 1994;107(6):1709-18.
7. Cheng J, Ogawa K, Kuriki K, et al. Increased intake of n-3 polyunsaturated fatty acids elevates the level of apoptosis in the normal sigmoid colon of patients polypectomized for adenomas/tumors. Cancer Lett 2003;193(1):17-24.
8. Spector AA. Essentiality of fatty acids. Lipids 1999;34 Suppl:S1-3.
9. Tokudome S, Nagaya T, Okuyama H, et al. Japanese versus Mediterranean diets and cancer. Asian Pac J Cancer Prev 2000;1(1):61-6.
10. Takeshita M, Ueda H, Shirabe K, Higuchi Y, Yoshida S. Lack of promotion of colon carcinogenesis by high-oleic safflower oil. Cancer (Phila.) 1997;79(8):1487-93.
11. Bartoli R, Fernandez-Banares F, Navarro E, et al. Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut 2000;46(2):191-9.
12. Pickering JS, Lupton JR, Chapkin RS. Dietary fat, fiber, and carcinogen alter fecal diacylglycerol composition and mass. Cancer Res 1995;55(11):2293-8.
13. Lee DY, Lupton JR, Aukema HM, Chapkin RS. Dietary fat and fiber alter rat colonic mucosal lipid mediators and cell proliferation. J Nutr 1993;123(11):1808-17.
14. Chapkin RS, Gao J, Lee DY, Lupton JR. Dietary fibers and fats alter rat colon protein kinase C activity: correlation to cell proliferation. J Nutr 1993;123(4):649-55.
15. Davidson LA, Lupton JR, Jiang YH, Chang WC, Aukema HM, Chapkin RS. Dietary fat and fiber alter rat colonic protein kinase C isozyme expression. J Nutr 1995;125(1):49-56.
16. Davidson LA, Lupton JR, Jiang YH, Chapkin RS. Carcinogen and dietary lipid regulate ras expression and localization in rat colon without affecting farnesylation kinetics. Carcinogenesis (Lond.) 1999;20(5):785-91.
17. Hong MY, Chapkin RS, Davidson LA, et al. Fish oil enhances targeted apoptosis during colon tumor initiation in part by down-regulating Bcl-2. Nutr Cancer 2003;46(1):44-51.
18. Bancroft LK, Lupton JR, Davidson LA, et al. Dietary fish oil reduces oxidative DNA damage in rat colonocytes. Free Radic Biol Med 2003;35(2):149-59.
19. Hong MY, Chapkin RS, Barhoumi R, et al. Fish oil increases mitochondrial phospholipid unsaturation, up-regulating reactive oxygen species and apoptosis in rat colonocytes. Carcinogenesis (Lond.) 2002;23(11):1919-25.
20. Murray NR, Weems C, Chen L, et al. Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon carcinogenesis. J Cell Biol 2002;157(6):915-20.
21. Chapkin RS, Hong MY, Fan YY, et al. Dietary n-3 PUFA alter colonocyte mitochondrial membrane composition and function. Lipids 2002;37(2):193-9.
22. Collett ED, Davidson LA, Fan YY, Lupton JR, Chapkin RS. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol 2001;280(5):C1066-75.
23. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 1997;57(16):3465-70.
24. Lee JY, Hwang DH. Docosahexaenoic acid suppresses the activity of peroxisome proliferator-activated receptors in a colon tumor cell line. Biochem Biophys Res Commun. 2002;298(5):667-74.
25. Narayanan BA, Narayanan NK, Simi B, Reddy BS. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Res 2003;63(5):972-9.
26. Reddy BS. Chemoprevention of colon cancer by dietary fatty acids. Cancer Metastasis Rev 1994;13(3-4):285-302.
27. Ramakrishnan R, Dorris D, Lublinsky A, et al. An assessment of Motorola CodeLink microarray performance for gene expression profiling applications. Nucleic Acids Res 2002;30(7):e30.
28. McLellan EA, Bird RP. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res 1988;48(21):6187-92.
29. 6-methylguanine DNA adduct levels in rat colon in part by increasing apoptosis during tumor initiation. Cancer Epidemiol Biomark Prev 2000;9(8):819-26.
30. Elder RH, Jansen JG, Weeks RJ, et al. Alkylpurine-DNA-N-glycosylase knockout mice show increased susceptibility to induction of mutations by methyl methanesulfonate. Mol Cell Biol 1998;18(10):5828-37.
31. Hong MY, Chapkin RS, Wild CP, et al. Relationship between DNA adduct levels, repair enzyme, and apoptosis as a function of DNA methylation by azoxymethane. Cell Growth Differ 1999;10(11):749-58.
32. McLellan EA, Medline A, Bird RP. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis (Lond.) 1991;12(11):2093-8.
33. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS system for mixed models. Cary, NC: SAS Publishing; 1996; p. 87-134.
34. Likhachev AJ, Margison GP, Montesano R. Alkylated purines in the DNA of various rat tissues after administration of 1,2-dimethylhydrazine. Chem Biol Interact 1977;18(2):235-40.
35. Tomlinson IP, Bodmer WF. Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models. Proc Natl Acad Sci USA 1995;92(24):11130-4.
36. Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998;339(18):1277-84.
37. Pretlow TP, O'Riordan MA, Somich GA, Amini SB, Pretlow TG. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis (Lond.) 1992;13(9):1509-12.
38. Fujimura H, Ino K, Nagasaka T, et al. Aminopeptidase A expression in cervical neoplasia and its relationship to neoplastic transformation and progression. Oncology 2000;58(4):342-52.
39. Ding X, Kaminsky LS. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 2003;43:149-73.
40. Guillemot F, Nagy A, Auerbach A, Rossant J, Joyner AL. Essential role of Mash-2 in extraembryonic development. Nature (Lond.) 1994;371(6495):333-6.
41. Ley K. Sulfated sugars for rolling lymphocytes. J Exp Med 2003;198(9):1285-8.
42. Shen WJ, Sridhar K, Bernlohr DA, Kraemer FB. Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein. Proc Natl Acad Sci USA 1999;96(10): 5528-32.
43. Das R, Hammamieh R, Neill R, Melhem M, Jett M. Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res 2001;7(6):1706-15.
44. Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol 1996;114(1):107-32.
45. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001;1(1):11-21.
46. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994;107 (Pt 12):3569-77.
47. Bedi A, Pasricha PJ, Akhtar AJ, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995;55(9):1811-6.
48. Bird RP, Lafave LM. Varying effect of dietary lipids and azoxymethane on early stages of colon Carcinogenesis: enumeration of aberrant crypt foci and proliferative indices. Cancer Detect Prev 1995;19(4):308-15.
49. Rao CV, Reddy BS. Modulating effect of amount and types of dietary fat on ornithine decarboxylase, tyrosine protein kinase and prostaglandins production during colon carcinogenesis in male F344 rats. Carcinogenesis (Lond.) 1993;14(7):1327-33.
50. Lee DY, Chapkin RS, Lupton JR. Dietary fat and fiber modulate colonic cell proliferation in an interactive site-specific manner. Nutr Cancer 1993;20(2):107-18.
51. Chang WC, Chapkin RS, Lupton JR. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis (Lond.) 1997;18(4):721-30.
52. Zoran DL, Turner ND, Taddeo SS, Chapkin RS, Lupton JR. Wheat bran diet reduces tumor incidence in a rat model of colon cancer independent of effects on distal luminal butyrate concentrations. J Nutr 1997;127(11):2217-25.
53. Narayanan BA, Narayanan NK, Reddy BS. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol 2001;19(6):1255-62.
54. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science (Wash. DC) 2001;294(5548):1866-70.
55. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 1997;94(9):4312-7.
56. Tan NS, Shaw NS, Vinckenbosch N, et al. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 2002;22(14):5114-27.
57. Helledie T, Jorgensen C, Antonius M, et al. Role of adipocyte lipid-binding protein (ALBP) and acyl-coA binding protein (ACBP) in PPAR-mediated transactivation. Mol Cell Biochem 2002;239(1-2):157-64.
58. Gupta RA, Sarraf P, Brockman JA, et al. Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22. J Biol Chem 2003;278(9):7431-8.
59. Lefebvre M, Paulweber B, Fajas L, et al. Peroxisome proliferator- activated receptor gamma is induced during differentiation of colon epithelium cells. J Endocrinol 1999;162(3):331-40.
60. Girnun GD, Smith WM, Drori S, et al. APC-dependent suppression of colon carcinogenesis by PPARgamma. Proc Natl Acad Sci USA 2002;99(21):13771-6.
61. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature (Lond.) 2001;411(6835):375-9.
62. Fan YY, Spencer TE, Wang N, Moyer MP, Chapkin RS. Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis (Lond.) 2003;24(9):1541-8.
63. Easwaran V, Pishvaian M, Salimuddin, Byers S. Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Curr Biol 1999;9(23):1415-8.
64. Palmer HG, Sanchez-Carbayo M, Ordonez-Moran P, Larriba MJ, Cordon-Cardo C, Munoz A. Genetic signatures of differentiation induced by lalpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res 2003;63(22):7799-806.